File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma

TitleA Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Authors
Yau, TCCLencioni, RSukeepaisarnjaroen, WChao, YYen, CJLausoontornsiri, WChen, PJSanpajit, TCamp, ACox, DSGagnon, RLiu, YRaffensperger, KEKulkarni, DKallender, HOttesen, LHPoon, RTPBottaro, DP
Issue Date2017
PublisherAmerican Association for Cancer Research. The Journal's web site is located at http://clincancerres.aacrjournals.org/
Citation
Clinical Cancer Research, 2017, v. 23 n. 10, p. 2405-2413 How to Cite?
DOI: http://dx.doi.org/10.1158/1078-0432.CCR-16-1789
Persistent Identifierhttp://hdl.handle.net/10722/236421
ISSN
1078-0432
2023 Impact Factor: 10.0
2023 SCImago Journal Rankings: 4.623
ISI Accession Number ID
WOS:000401254300005

 

DC FieldValueLanguage
dc.contributor.authorYau, TCC-
dc.contributor.authorLencioni, R-
dc.contributor.authorSukeepaisarnjaroen, W-
dc.contributor.authorChao, Y-
dc.contributor.authorYen, CJ-
dc.contributor.authorLausoontornsiri, W-
dc.contributor.authorChen, PJ-
dc.contributor.authorSanpajit, T-
dc.contributor.authorCamp, A-
dc.contributor.authorCox, DS-
dc.contributor.authorGagnon, R-
dc.contributor.authorLiu, Y-
dc.contributor.authorRaffensperger, KE-
dc.contributor.authorKulkarni, D-
dc.contributor.authorKallender, H-
dc.contributor.authorOttesen, LH-
dc.contributor.authorPoon, RTP-
dc.contributor.authorBottaro, DP-
dc.date.accessioned2016-11-25T00:53:09Z-
dc.date.available2016-11-25T00:53:09Z-
dc.date.issued2017-
dc.identifier.citationClinical Cancer Research, 2017, v. 23 n. 10, p. 2405-2413-
dc.identifier.issn1078-0432-
dc.identifier.urihttp://hdl.handle.net/10722/236421-
dc.languageeng-
dc.publisherAmerican Association for Cancer Research. The Journal's web site is located at http://clincancerres.aacrjournals.org/-
dc.relation.ispartofClinical Cancer Research-
dc.titleA Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma-
dc.typeArticle-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.emailPoon, RTP: poontp@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1158/1078-0432.CCR-16-1789-
dc.identifier.pmid27821605-
dc.identifier.scopuseid_2-s2.0-85020386314-
dc.identifier.hkuros270529-
dc.identifier.hkuros270733-
dc.identifier.volume23-
dc.identifier.issue10-
dc.identifier.spage2405-
dc.identifier.epage2413-
dc.identifier.isiWOS:000401254300005-
dc.publisher.placeUnited States-
dc.identifier.issnl1078-0432-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats